AAAAAA

   
Results: 1-23 |
Results: 23
PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER
Authors: FLEMING GF KUGLER JW HOFFMAN PC ANSARI R BITRAN JD KLEPSCH A MALONE D FASANMADE AA RATAIN MJ VOKES EE
Citation: Gf. Fleming et al., PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2032-2037
CANCER CARE DURING THE LAST PHASE OF LIFE
Authors: SCHNIPPER L BITRAN JD BLANK LL BLUM D BROCK D BRUERA E EMANUEL EJ FOLEY KM GORDON DS HILDEN JM KAGAN RA LEVY MH LICHTER AS LINK MP PENLEY WC SMITH TJ STANLEY K STOVALL E TOKAZ LK WOOD WC MAYER R
Citation: L. Schnipper et al., CANCER CARE DURING THE LAST PHASE OF LIFE, Journal of clinical oncology, 16(5), 1998, pp. 1986-1996
HIGH-DOSE CHEMOTHERAPY CONSOLIDATION WITH AUTOLOGOUS STEM-CELL RESCUEIN METASTATIC BREAST-CANCER - A 10-YEAR EXPERIENCE
Authors: LAPORT GF GRAD G GRINBLATT DL BITRAN JD WILLIAMS SF
Citation: Gf. Laport et al., HIGH-DOSE CHEMOTHERAPY CONSOLIDATION WITH AUTOLOGOUS STEM-CELL RESCUEIN METASTATIC BREAST-CANCER - A 10-YEAR EXPERIENCE, Bone marrow transplantation, 21(2), 1998, pp. 127-132
REGRESSION OF METASTATIC CARCINOMA OF THE SKIN APPENDAGES AFTER INTRALESIONAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: GOKER H BITRAN JD
Citation: H. Goker et Jd. Bitran, REGRESSION OF METASTATIC CARCINOMA OF THE SKIN APPENDAGES AFTER INTRALESIONAL GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Annals of internal medicine, 129(6), 1998, pp. 509-509
HER2 NEU OVEREXPRESSION IS ASSOCIATED WITH TREATMENT FAILURE IN WOMENWITH HIGH-RISK STAGE-II AND STAGE IIIA BREAST-CANCER (GREATER-THAN-10INVOLVED LYMPH-NODES) TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOLLOWING STANDARD-DOSE ADJUVANT CHEMOTHERAPY/
Authors: BITRAN JD SAMUELS B TRUJILLO Y KLEIN L SCHROEDER L MARTINEC J
Citation: Jd. Bitran et al., HER2 NEU OVEREXPRESSION IS ASSOCIATED WITH TREATMENT FAILURE IN WOMENWITH HIGH-RISK STAGE-II AND STAGE IIIA BREAST-CANCER (GREATER-THAN-10INVOLVED LYMPH-NODES) TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC PROGENITOR-CELL SUPPORT FOLLOWING STANDARD-DOSE ADJUVANT CHEMOTHERAPY/, Clinical cancer research, 2(9), 1996, pp. 1509-1513
A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS
Authors: ROMANUNFER S BITRAN JD GARRISON L PROESCHEL C HANAUER S SCHROEDER L JOHNSON L KLEIN L MARTINEC J
Citation: S. Romanunfer et al., A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 24(7), 1996, pp. 823-828
TANDEM HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS YIELDS PROLONGED SURVIVAL IN STAGE-IV BREAST-CANCER
Authors: BITRAN JD SAMUELS B KLEIN L HANAUER S JOHNSON L MARTINEC J HARRIS E KEMPLER J WHITE W
Citation: Jd. Bitran et al., TANDEM HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS YIELDS PROLONGED SURVIVAL IN STAGE-IV BREAST-CANCER, Bone marrow transplantation, 17(2), 1996, pp. 157-162
A PHASE-I STUDY OF IFOSFAMIDE AND DOXORUBICIN WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN STAGE-IV BREAST-CANCER
Authors: BITRAN JD SAMUELS BL MARSIK S GAMBINO A WHITE L
Citation: Jd. Bitran et al., A PHASE-I STUDY OF IFOSFAMIDE AND DOXORUBICIN WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN STAGE-IV BREAST-CANCER, Clinical cancer research, 1(2), 1995, pp. 185-188
COST-EFFECTIVENESS ANALYSIS - SLEEPING WITH AN ENEMY OR A FRIEND
Authors: GULATI SC BITRAN JD
Citation: Sc. Gulati et Jd. Bitran, COST-EFFECTIVENESS ANALYSIS - SLEEPING WITH AN ENEMY OR A FRIEND, Journal of clinical oncology, 13(9), 1995, pp. 2152-2154
HIGH-DOSE INTRAVENOUS MELPHALAN - A REVIEW
Authors: SAMUELS BL BITRAN JD
Citation: Bl. Samuels et Jd. Bitran, HIGH-DOSE INTRAVENOUS MELPHALAN - A REVIEW, Journal of clinical oncology, 13(7), 1995, pp. 1786-1799
A PHASE-II STUDY OF RECOMBINANT INTERFERON-GAMMA FOLLOWING COMBINATION CHEMOTHERAPY FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER
Authors: BITRAN JD GREEN M PERRY M HOLLIS DR HERNDON JE
Citation: Jd. Bitran et al., A PHASE-II STUDY OF RECOMBINANT INTERFERON-GAMMA FOLLOWING COMBINATION CHEMOTHERAPY FOR PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 18(1), 1995, pp. 67-70
ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA FOLLOWING INTENSIVE CHEMOTHERAPY FOR BREAST-CANCER
Authors: ROMANUNFER S BITRAN JD HANAUER S JOHNSON L RITA D BOOTH C CHEN K
Citation: S. Romanunfer et al., ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA FOLLOWING INTENSIVE CHEMOTHERAPY FOR BREAST-CANCER, Bone marrow transplantation, 16(1), 1995, pp. 163-168
DOSE INTENSIFICATION - A PHASE-I STUDY OF IFOSFAMIDE WITH VINORELBINE(NAVELBINE) - RATIONALE AND STUDY DESIGN IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: DRINKARD LC HOFFMAN PC SAMUELS BL WATSON S BITRAN JD GOLOMB HM VOKES EE
Citation: Lc. Drinkard et al., DOSE INTENSIFICATION - A PHASE-I STUDY OF IFOSFAMIDE WITH VINORELBINE(NAVELBINE) - RATIONALE AND STUDY DESIGN IN ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 22(2), 1995, pp. 30-37
A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS
Authors: BITRAN JD ROMANUNFER S GARRISON L PROESCHEL C SCHROEDER L JOHNSON L MARTINEC J KLEIN L
Citation: Jd. Bitran et al., A PHASE-II STUDY OF CYCLOPHOSPHAMIDE FOLLOWED BY PIXY321 AS A MEANS OF MOBILIZING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS, Blood, 86(10), 1995, pp. 2303-2303
A PHASE-II TRIAL OF NEOADJUVANT CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER
Authors: GRADISHAR WJ HARAF DJ HOFFMAN PC RADEMAKER AW FERGUSON MK GOLOMB H BITRAN JD VOKES EE
Citation: Wj. Gradishar et al., A PHASE-II TRIAL OF NEOADJUVANT CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER, Oncology Reports, 1(5), 1994, pp. 957-962
CONCOMITANT CHEMORADIOTHERAPY FOR NONSMALL CELL LUNG-CANCER
Authors: VOKES EE HARAF DJ HOFFMAN PC BITRAN JD FERGUSON MK GOLOMB HM
Citation: Ee. Vokes et al., CONCOMITANT CHEMORADIOTHERAPY FOR NONSMALL CELL LUNG-CANCER, Lung cancer, 10, 1994, pp. 190000253-190000261
A PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN AUGMENTED BY VINORELBINE (NAVELBINE) FOR ADVANCED NONSMALL CELL LUNG-CANCER -RATIONALE AND STUDY DESIGN
Authors: VOKES EE DRINKARD LC SAMUELS BL HOFFMAN PC WATSON S BITRAN JD HARAF DJ FERGUSON MF GOLOMB HM CRAWFORD J OROURKE MA GRALLA R
Citation: Ee. Vokes et al., A PHASE-II STUDY OF CISPLATIN, 5-FLUOROURACIL, AND LEUCOVORIN AUGMENTED BY VINORELBINE (NAVELBINE) FOR ADVANCED NONSMALL CELL LUNG-CANCER -RATIONALE AND STUDY DESIGN, Seminars in oncology, 21(5), 1994, pp. 79-84
NON-SMALL-CELL LUNG-CANCER - TOWARD THE NEXT PLATEAU
Authors: VOKES EE BITRAN JD
Citation: Ee. Vokes et Jd. Bitran, NON-SMALL-CELL LUNG-CANCER - TOWARD THE NEXT PLATEAU, Chest, 106(3), 1994, pp. 659-661
ON THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
Authors: DEVRIES BC BITRAN JD
Citation: Bc. Devries et Jd. Bitran, ON THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS, Chest, 105(1), 1994, pp. 1-2
MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL HARVESTS UTILIZING CYCLOPHOSPHAMIDE AND P1XY321
Authors: BITRAN JD HANAUER S JOHNSON L MARTINEC J KLEIN L
Citation: Jd. Bitran et al., MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL HARVESTS UTILIZING CYCLOPHOSPHAMIDE AND P1XY321, Blood, 84(10), 1994, pp. 10000733-10000733
MITOXANTRONE, VINCRISTINE, AND 5-FLUOROURACIL WITH LEUCOVORIN MODULATION AS INDUCTION CHEMOTHERAPY PRIOR TO HIGH-DOSE INTENSIFICATION IN METASTATIC BREAST-CANCER
Authors: WILLIAMS SF MYERS SE HUFFMAN S MICK R BITRAN JD
Citation: Sf. Williams et al., MITOXANTRONE, VINCRISTINE, AND 5-FLUOROURACIL WITH LEUCOVORIN MODULATION AS INDUCTION CHEMOTHERAPY PRIOR TO HIGH-DOSE INTENSIFICATION IN METASTATIC BREAST-CANCER, Breast cancer research and treatment, 28(3), 1993, pp. 291-294
AUTOLOGOUS BONE-MARROW TRANSPLANTATION USING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS - THE TOTAL NUMBER OF CD34+ CELLS KG PREDICTS FOR HEMATOLOGIC ENGRAFTMENT/
Authors: BITRAN JD MARTINEC J OKUNO T WHITE L HANAUER S KLEIN L SAMUELS B
Citation: Jd. Bitran et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION USING PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS - THE TOTAL NUMBER OF CD34+ CELLS KG PREDICTS FOR HEMATOLOGIC ENGRAFTMENT/, Blood, 82(10), 1993, pp. 10000288-10000288
MALIGNANCIES OF UNDETERMINED PRIMARY ORIGIN
Authors: BITRAN JD ULTMANN JE
Citation: Jd. Bitran et Je. Ultmann, MALIGNANCIES OF UNDETERMINED PRIMARY ORIGIN, Disease-a-month, 38(4), 1992, pp. 215
Risultati: 1-23 |